Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational, Open Label, Post Marketing Study to Evaluate the Safety and Effectiveness of Hoat Huyet Nhat Nhat Compared With Gingko Biloba EGb761 (Tanakan 40mg) in Patients With Symptoms Related to the Insufficient Blood Supply to the Brain

NCT03216681 is registered in ClinicalTrials.gov with Nhat Nhat Pharmaceutical Company as lead sponsor.

NCT NCT03216681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03216681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational, Open Label, Post Marketing Study to Evaluate the Safety and Effectiveness of Hoat Huyet Nhat Nhat Compared With Gingko Biloba EGb761 (Tanakan 40mg) in Patients With Symptoms Related to the Insufficient Blood Supply to the Brain
Lead sponsor
Nhat Nhat Pharmaceutical Company
Phase
Observational
Overall status
Completed
Start date
July 1, 2017
Completion date
April 30, 2018
Enrollment
750 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insufficient blood supply to the brain